Brief: BioArctic Q2 Operating Profit SEK 179.1 Million
28/08/2025 07:00
Aug 28 (Reuters) - BioArctic Q2 adjusted EPS SEK 1.09. Q2 revenue SEK 392.1 million Q2 adjusted free cash flow SEK 1,147.1 million Q2 net income SEK 96.6 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln